A Simple Strategy for Managing ADDWritten by ADD Coach Jennifer Koretsky
A Simple Strategy for Managing ADD By ADD Coach Jennifer Koretsky © Copyright 2003 As an ADD Coach, I usually begin my conversations with new and potential clients by saying, “Tell me about yourself and why you’re looking for coaching.” Most people answer with a long list of their ADD challenges. Very few people answer that they are looking to discover, enhance, or utilize their strengths. This is a big part of coaching, and a part that many people need a lot of help with. Unfortunately, many ADDers spend too much of their time focusing on what they think they do wrong. This is understandable; as most of us have spent a lifetime learning how to deal with attention inconsistency, impulsivity, hyperactivity, emotional reactivity, and other challenges that our ADD has presented. However, few of us actually take time to appreciate our ability to manage these challenges and bounce back from difficult times. And when we don’t balance good stuff with not-so-good stuff, we can become frustrated, unmotivated, and unhappy. Every single person in this world has strengths and interests – things we do well and things we like to do. Learning to focus some time on those strengths and interests
| | Cetyl Myristoleate for Arthritis Science or SpeculationWritten by Rusty Ford
Cetyl Myristoleate for Arthritis Science for Speculation By Rusty FordThere are a lot of fabulous stories about Cetyl Myristoleate (also known as CMO or CM) floating across Internet. Mine is one of them. There have been a number of articles published in little known journals or magazines. There have been four small booklets published. One making fantastic claims, all four filled with anecdotal evidence but offering no real research to back up claims. There are a number of Doctors sharing results they are having with their patients but so does every other wonder-working product. The question is, are there any scientific studies to back up any of these claims? The answer is yes. To date there are several patient studies and two double blind studies completed. I will mention three most prominent below. Dr Len Sands of San Diego Clinic completed first human study on effectiveness on Cetyl Myristoleate in 1995. There were 48 arthritis patients in this study. All but two showed significant improvement in articular mobility (80% or better) and reduction of pain (70% or better). Obviously study had its flaws. One doctor conducted study, there was no control group and number of participants was small. Even so, it suggested to many that maybe there was some hope here and that more scientific studies should follow. The first double blind study followed two years later. Dr. H. Siemandi conducted a double blind study under auspices of Joint European Hospital Studies Program. There were 431 patients in study, 106 who received cetyl myristoleate, 99 who received cetyl myristoleate, and glucosamine, sea cucumber, and hydrolyzed cartilage and 226 who received a placebo. Clinical assessment included radiological test and other studies. Results were 63% improvement for cetyl myristoleate group, 87% for cetyl myristoleate plus glucosamine group and 15% for placebo group.
|
